Author Question: When planning care for a patient who is receiving filgrastim (Neupogen) for a nonmyeloid malignancy, ... (Read 63 times)

sheilaspns · **on:** Jul 23, 2018

When planning care for a patient who is receiving filgrastim (Neupogen) for a nonmyeloid malignancy, the nurse should formulate which of the following patient outcomes? (Select all that apply.)

A) The patient will not develop an infection.
B) The patient will not experience bone pain.
C) The patient will be able to self-administer filgrastim at home.
D) The patient will not develop febrile neutropenia.
E) The patient will not retain fluid.

Question 2

A 3-month-old infant has been diagnosed with respiratory syncytial virus (RSV) and will begin treatment with inhaled ribavirin. Which of the following measures should be taken in the care of this patient and administration of ribavirin?

A) Serial sputum samples should be obtained daily for the duration of treatment.
B) Pulmonary function testing should be performed immediately before and 30 minutes after each dose of the drug.
C) Nurses who are pregnant or who may be pregnant should not administer the drug.
D) The drug should be administered by a physician or a nurse practitioner.